A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan
Congenital Anomalies · 2025
DOI: 10.1111/cga.12588 ↗Kurz gefasst
Fachartikel in der Zeitschrift Congenital Anomalies, 2025. Verfasst von Mariko Honma und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, Niigata University Medical & Dental Hospital, Niigata, Japan. Hauptthemen laut MEDLINE: Pregnancy Trimester, First, Cephalosporins, Pregnancy Outcome, Anti-Bacterial Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben.
Abstract (Originalsprache)
We evaluated the teratogenic risk associated with exposure to cefditoren pivoxil during the first trimester of pregnancy using the integrated databases of the Toranomon Hospital and the National Center for Child Health and Development. Among 13 599 registered individuals, the analysis included 285 subjects who had taken cefditoren pivoxil during the first trimester of pregnancy. The rates of stillbirth, miscarriage, and elective terminations were 0.4%, 5.6%, and 2.1%, respectively. Among 262 live births, the rates of preterm birth, low birth weight, and major congenital malformations were 4.6%, 5.7%, and 1.2%, respectively. Our results suggest that exposure to cefditoren pivoxil during the first trimester of pregnancy does not significantly increase the risk of adverse pregnancy outcomes and infant outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, Niigata University Medical & Dental Hospital, Niigata, Japan.
- National Center for Child Health and Development, The Japan Drug Information Institute in Pregnancy, Tokyo, Japan.
- Department of Pharmaceutical Sciences, Tohoku University Hospital, Sendai, Japan.
- Department of Preventive Medicine and Epidemiology, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
- Department of Molecular Epidemiology, Graduate School of Medicine, Tohoku University, Sendai, Japan.
- Department of Health Informatics, Graduate School of Medicine and School of Public Health, Kyoto University, Kyoto, Japan.
ORCID-Profile: Mikako Goto, Taku Obara, Kunihiko Takahashi
Zitieren
APA
Honma, M., Suzuki, N., Goto, M., Obara, T., Saito, Y., Nakajima, K., Yamane, R., Takahashi, K., Nakayama, T., Hayashi, M., Murashima, A., & Toyama, A. (2025). A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan. Congenital Anomalies. https://doi.org/10.1111/cga.12588
Vancouver
Honma M, Suzuki N, Goto M, Obara T, Saito Y, Nakajima K, et al. A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan. Congenital Anomalies. 2025. doi:10.1111/cga.12588
BibTeX
@article{Honma2025,
author = {Honma, Mariko and Suzuki, Naoto and Goto, Mikako and Obara, Taku and Saito, Yoshiyuki and Nakajima, Ken and Yamane, Ritsuko and Takahashi, Kunihiko and Nakayama, Takeo and Hayashi, Masahiro and Murashima, Atsuko and Toyama, Akira},
title = {A case series study on the safety of cefditoren pivoxil use during the first trimester of pregnancy in Japan},
journal = {Congenital Anomalies},
year = {2025},
doi = {10.1111/cga.12588}
}
EUVIMED